There is emerging evidence that radiotherapy promotes molecular mechanisms (e.g. vascular endothelial growth factor and p53) within rectal cancer, which contribute to tumour growth, survival, and subsequent RT resistance. The gene discussed is TP53; the disease is neoplasm.